Khaldoon Alaswad, M.D., right, director, cardiac catheterization lab, during a complex CTO procedure at Henry Ford Hospital.

Henry Ford Hospital thought leaders regularly speak at the cardiology conferences about new research and technology innovations. So, it was an honor when DAIC was invited to conduct a site visit at Henry Ford recently to tour its facilities, sit in on procedures and conduct numerous video interviews to better understand the workings of the institution. 

I recently had the opportunity to conduct an onsite visit to the University of Colorado Hospital Heart and Vascular Center at the Anschutz Medical Campus in Aurora, Colo., which is part of UCHealth.

Feb. 6, 2026 — Robert Wood Johnson University Hospital (RWJUH), in partnership with Rutgers Robert Wood Johnson Medical School (RWJMS), has earned The Joint Commission’s (TJC) Gold Seal of Approval  as a Comprehensive Cardiac Center (CCC) and the American Heart Association’s (AHA) Heart-Check Mark for Disease-Specific Certification.

Feb. 6, 2026 — Abbott has announced new clinical data from two late-breaking presentations at AF Symposium in Boston (Feb. 5-7, 2026) that demonstrate the strong safety and efficacy of the company's minimally invasive therapies to treat people with atrial fibrillation (AFib).

Coronary CT angiography reshapes cath lab planning and patient care.

Advances in coronary CT angiography (CCTA) over the past two decades have helped cardiologists detect heart disease in asymptomatic patients more accurately. Now, providers are using dedicated cardiac CT scanners to plan treatments and improve patient care. Innovations like the Arineta Spotlight Duo bring greater visibility than traditional 64-slice scanners, expanding what’s possible for providers and patients.

Feb. 3, 2026 — The first official summit of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) organized directly under the umbrella of the European Society of Cardiology (ESC) will take place in Munich, Germany Feb.19 and 20, 2026.

Feb. 3, 2026 — Medtronic plc announced it will exercise its option to acquire CathWorks, a privately held medical device company, which aims to transform how coronary artery disease (CAD) is diagnosed and treated.

The intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the CathWorks FFRangio System in the U.S., Europe and Japan, where it is commercially available.  

Feb. 3, 2026 — Bristol Myers Squibb has launched "Change the Target. Change What’s Possible," an educational campaign developed in partnership with Johnson & Johnson for clinicians who manage cardiovascular and thromboembolic conditions. The program spotlights the unmet need in cardiovascular care for patients who, despite currently available therapies, remain at high risk of thromboembolic events, underscoring the need for new innovations to help address one of the leading causes of death in the U.S.

Feb. 2, 2026 — Brainomix, a provider of AI-powered imaging tools in stroke and lung fibrosis, is introducing its new Brainomix 360 Next Generation platform at the International Stroke Conference (ISC), taking place Feb. 4-6, 2026, in New Orleans.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now